|
|
|
 |
FDA Approval Activities for this Drug…
Eloxatin (oxaliplatin) for Injection, Sanofi-Synthelabo, NDA 21-492/S1 1/14/03 1/23/03 Eloxatin (oxaliplatin) for Injection, Sanofi-Synthelabo, NDA 21-492 Eloxatin (oxaliplatin) Injection, Sanofi-Synthelabo, Inc. | Eloxatin (Oxaliplatin) Injection, Sanofi-Synthelabo, New or Modified Indication | ELOXATIN (oxaliplatin) Injection, Sanofi-Synthelabo, Approval | ELOXATIN (oxaliplatin) injection, Sanofi, Labeling Revision | Eloxatin (oxaliplatin) Injection, Sanofi-Aventis, Labeling Revision | Eloxatin (oxaliplatin) Injection, Sanofi-Aventis, Efficacy Supp. w/Clinical Data | Eloxatin (oxaliplatin) Injection, Sanofi-Aventis US, Inc., Labeling Revision | Eloxatin (oxaliplatin) Injection, Sanofi-Aventis US, Inc., Efficacy Supplement with Clinical Data to Support | Eloxatin (oxaliplatin) I.V. Injection, Sanofi-Aventis U.S., Labeling Revision | Eloxatin (oxaliplatin) I.V. Injection, Sanofi-Aventis U.S., Labeling Revision | Oxaliplatin Injection, Ebewe Pharma, Tentative Approval | Oxaliplatin Injection, Fresenius Kabi Oncology Plc., Tentative Approval | Oxaliplatin Injection, Hospira Worldwide PTY, Tentative Approval | Oxaliplatin Injection, Sun Pharmaceutical Industries, Ltd., Tentative Approval | Oxaliplatin Injection, Teva Parenteral Medicines, Inc., Tentative Approval | Oxaliplatin Injection, Hospira Worldwide Pty, Tentative Approval | Oxaliplatin Injection, Sandoz Inc., Tentative Approval | Oxaliplatin Injection, Mustafa Nevsat Ilac Sanayii A.S., Tentative Approval | Oxaliplatin I.V. Injection, Fresenius Kabi Oncology Plc., Approval | Oxaliplatin I.V. Injection, EBEWE Pharma, Approval | Oxaliplatin I.V. Injection, Hospira Worldwide PTY, Tentative Approval | Oxaliplatin I.V. Injection, Sun Pharma Global, Approval | Oxaliplatin Injection, Hospira Worldwide, Inc., Approval | Oxaliplatin Injection, Actavis Totowa, Tentative Approval | Oxaliplatin Injection, Pliva Lachema, Approval | Oxaliplatin Injection, APP Pharmaceuticals, Approval | Oxaliplatin I.V. Injection, Fresenius Kabi Oncology Plc., Approval | Oxaliplatin I.V. Injection, Sandoz, Inc., Approval | Oxaliplatin Injection, Onco Therapies, Ltd., Tentative Approval | Oxaliplatin Injection, Onco Therapies Ltd., Tentative Approval | Eloxatin, oxaliplatin, Injectable; Iv (Infusion), Sanofi Aventis Us, Labeling Revision | Eloxatin, oxaliplatin, Injectable; Iv (Infusion), Sanofi Aventis Us, Labeling Revision
  
|